Kennedy Krieger Institute–Johns Hopkins NeuroNEXT Site
Official title: Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site
Funded at Hugo W. Moser Res Inst Kennedy Krieger · NIH-11399298 · Data updated 2026-11-12
A pediatric and adult neurology trials network site aims to help run early-stage trials for brain-related conditions more smoothly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hugo W. Moser Res Inst Kennedy Krieger NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $428,295 |
| NIH project number | 5U24NS134009-04 |
| Project ID | NIH-11399298 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children and adults with acquired brain injury or other neurological conditions who may participate in early-phase clinical trials.
✕Less likely to help
Patients not eligible for the specific trials or those not seeking trial participation may not directly benefit.
What this research studies
This grant supports the Kennedy Krieger Institute and Johns Hopkins University to serve as a NeuroNEXT site, helping to design and run early-phase trials for neurological conditions with a focus on pediatric populations and community engagement. The team uses centralized review and master trial agreements to speed trial start-up, making participation easier for patients and families. By training and mentoring the next generation of neurology trialists, the site seeks to improve trial quality and access to new therapies for people with brain injuries and other neurological disorders.
Why it matters
Potential benefit: If successful, patients could gain faster access to promising new therapies and experience improved trial experiences through streamlined processes.
How similar studies have gone: NeuroNEXT has previously accelerated trial start-up and supported timely enrollment in multiple neurological conditions.
Where this research is happening
-
Hugo W. Moser Res Inst Kennedy Krieger
Baltimore, United States Active
Researchers
- Principal investigator: Augustine, Erika — Hugo W. Moser Res Inst Kennedy Krieger
- Study coordinator: Augustine, Erika
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.